New Key Statistics Module, Z-Score and F-Score
OTCPK:KHTRF Key Ratios
| Market Cap $ M | 373.74 |
| Enterprise Value $ M | 294.52 |
| P/E(ttm) | -- |
| PE Ratio without NRI | 72.16 |
| Forward PE Ratio | 64.49 |
| Price/Book | 0.70 |
| Price/Sales | 1.56 |
| Price/Free Cash Flow | 26.83 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 257.00 |
| EPS (TTM) $ | -0.21 |
| Beneish M-Score | -2.7 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 9.00 |
| y-y EBITDA Growth Rate % | -37.40 |
| EV-to-EBIT | -20.10 |
| EV-to-EBITDA | 14.39 |
| PEG | 8.02 |
| Shares Outstanding M | 100.80 |
| Net Margin (%) | -8.81 |
| Operating Margin % | 2.95 |
| Pre-tax Margin (%) | -9.17 |
| Quick Ratio | 2.39 |
| Current Ratio | 3.36 |
| ROA % (ttm) | -3.18 |
| ROE % (ttm) | -3.98 |
| ROIC % (ttm) | 1.41 |
| Dividend Yield % | -- |
| Altman Z-Score | 2.56 |
KHTRF Number of Guru Trades
KHTRF Volume of Guru Trades
Gurus Latest Trades with OTCPK:KHTRF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:KHTRF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Knight Therapeutics Inc Insider Transactions
No Available Data
News about OTCPK:KHTRF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers